Position in UTHR
as of Mar 31, 2026
· filed May 13, 2026
Position Value
$2,774,553
+$588,263 QoQ
Shares Held
4,679
+4.3% QoQ
Ownership
0.011%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Sep 2020
23 quarters on record
Voting authority
Sole 100.ToString("F0")%
Shared 0.ToString("F0")%
None 0.ToString("F0")%
Common Shares in UTHR Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Mar 31, 2026MACKENZIE FINANCIAL CORP holds $105,409,906 across 15 Drug Manufacturers - Specialty & Generic names. UTHR ranks #7 (2.6% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LNTH |
Lantheus Holdings, Inc.
|
714,561 | $54,199,451 | |
| 2 | NBIX |
Neurocrine Biosciences Inc
|
91,677 | $12,077,527 | |
| 3 | ALKS |
Alkermes plc.
|
249,182 | $8,811,075 | |
| 4 | VTRS |
Viatris Inc
|
534,364 | $7,219,257 | |
| 5 | ZTS |
Zoetis Inc.
|
54,702 | $6,466,323 | |
| 6 | PAHC |
Phibro Animal Health Corp
|
75,044 | $4,150,683 | |
| 7 | UTHR |
UNITED THERAPEUTICS Corp
This page
|
4,679 | $2,774,553 | |
| 8 | BCRX |
Biocryst Pharmaceuticals Inc
|
243,416 | $2,317,320 |
All Filings in UTHR
Export CSV
23 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $2,774,553 | 4,679 | Shares | Sole | 2026-05-13 | |
| 2025-12-31 | $2,186,290 | 4,487 | Shares | Sole | 2026-02-18 | |
| 2025-09-30 | $406,633 | 970 | Shares | Sole | 2025-11-13 | |
| 2025-06-30 | $1,007,161 | 3,505 | Shares | Sole | 2025-08-13 | |
| 2025-03-31 | $803,351 | 2,606 | Shares | Sole | 2025-05-07 | |
| 2024-12-31 | $937,495 | 2,657 | Shares | Sole | 2025-05-02 | |
| 2024-09-30 | $1,020,580 | 2,848 | Shares | Sole | 2024-11-13 | |
| 2024-06-30 | $4,862,028 | 15,263 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | $5,145,728 | 22,400 | Shares | Sole | 2024-05-10 | |
| 2023-12-31 | $3,976,270 | 18,083 | Shares | Sole | 2024-01-30 | |
| 2023-09-30 | $3,774,739 | 16,712 | Shares | Sole | 2023-10-25 | |
| 2023-06-30 | $4,697,118 | 21,278 | Shares | Sole | 2023-08-03 | |
| 2023-03-31 | $4,893,302 | 21,849 | Shares | Sole | 2023-04-24 | |
| 2022-12-31 | $6,524,269 | 23,461 | Shares | Sole | 2023-02-14 | |
| 2022-09-30 | $6,684,037 | 31,923 | Shares | Sole | 2022-10-07 | |
| 2022-06-30 | $8,338,592 | 35,387 | Shares | Sole | 2022-08-10 | |
| 2022-03-31 | $7,831,964 | 43,654 | Shares | Sole | 2022-05-13 | |
| 2021-12-31 | $3,326,335 | 15,394 | Shares | Sole | 2022-02-14 | |
| 2021-09-30 | $1,309,410 | 7,094 | Shares | Sole | 2021-11-08 | |
| 2021-06-30 | $1,649,495 | 9,194 | Shares | Sole | 2021-08-11 | |
| 2021-03-31 | $1,855,693 | 11,094 | Shares | Sole | 2021-05-14 | |
| 2020-12-31 | $1,243,767 | 8,194 | Shares | Sole | 2021-02-10 | |
| 2020-09-30 | $792,850 | 7,850 | Shares | Sole | 2020-11-13 | |
| No filing history on record for this holder in this stock. | ||||||